<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Reconstructive materials used in surgery: Classification and host response
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Reconstructive materials used in surgery: Classification and host response
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Reconstructive materials used in surgery: Classification and host response
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Emanuel C Trabuco, MD, MS
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John B Gebhart, MD, MS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Linda Brubaker, MD, FACOG
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Amy S Colwell, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Russell S Berman, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kathryn A Collins, MD, PhD, FACS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 06, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         This topic review will discuss the classification and histologic behavior of reconstructive materials used in surgery. Prosthetic materials in the surgical management of specific conditions are discussed in individual topic reviews.
        </p>
        <p>
         The indications for and techniques for placing such materials are reviewed separately.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          TYPES OF MATERIALS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Surgical reconstructive materials differ by source and include synthetic mesh, autografts, allografts, and xenografts. The advantages and disadvantages of the different material types are found in the table  (
         <a class="graphic graphic_table graphicRef72868" href="/z/d/graphic/72868.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Synthetic materials
         </span>
         <span class="headingEndMark">
          —
         </span>
         Synthetic materials are available as both absorbable (eg, polyglactin 910 [Vicryl], polyglycolic acid [Dexon]) and nonabsorbable mesh (eg, polypropylene [Marlex, Prolene] and expanded polytetrafluoroethylene [ePTFE, Gore-tex]). Compared with biologic grafts, advantages of synthetic materials include greater availability (does not require harvesting) and lower cost of the material. However, infectious and erosion complications, especially with transvaginal surgery, have prompted a search for alternative materials [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="local">
          'Host response'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Autografts
         </span>
         <span class="headingEndMark">
          —
         </span>
         Autograft materials are harvested from the patient undergoing the procedure. Skin autografting is the basis for burn reconstruction, and various tissue flaps can provide coverage for complex soft tissue defects. Tensor fascia lata and rectus fascia, the most commonly used autografts for stress urinary incontinence surgery (eg, bladder neck sling), have been used for decades and yield predictable results [
         <a href="#rid2">
          2
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/15118.html" rel="external">
          "Skin autografting"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/114188.html" rel="external">
          "Overview of flaps for soft tissue reconstruction"
         </a>
         .)
        </p>
        <p>
         A clear advantage of autografts is that the host response is rarely problematic. However, the use of autografts is limited by morbidity associated with harvesting the tissue (eg, pain, bleeding, infection, hernia formation), as well as varying size, quantity, and quality of tissue [
         <a href="#rid3">
          3
         </a>
         ]. (See
         <a class="local">
          'Host response'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Allografts
         </span>
         <span class="headingEndMark">
          —
         </span>
         Allografts are processed cadaveric fascia lata or acellular dermal matrices (ADM) from human donors  (
         <a class="graphic graphic_table graphicRef63852" href="/z/d/graphic/63852.html" rel="external">
          table 2
         </a>
         ). The material is decellularized and rendered nonimmunogenic by washing processes, which are designed to remove cellular debris without permanently damaging the connective tissue scaffold. (See
         <a class="medical medical_review" href="/z/d/html/118064.html" rel="external">
          "Skin substitutes"
         </a>
         .)
        </p>
        <p>
         Although tissue banks in North America are accredited through the American Association of Tissue Banks (AATB), evidence-based comparisons among allografts distributed by different companies are difficult because the harvesting, processing, and preservation of these materials are varied and proprietary. (See
         <a class="local">
          'Allograft processing'
         </a>
         below.)
        </p>
        <p>
         Human donors of allografts are screened for blood-borne pathogens; those with risk factors or who test positive for HIV, syphilis, HTLV, or hepatitis B or C are excluded. There have been no reported cases of donor-related infection with these viral infections associated with the use of allografts.
        </p>
        <p>
         With respect to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the Physicians Council of the AATB assessed the prospects for mitigating the risk relating to coronavirus disease 2019 (COVID-19) [
         <a href="#rid4">
          4
         </a>
         ]. While testing is available using polymerase chain reaction (PCR), usually from oropharyngeal or nasopharyngeal samples, these diagnostic tests have not been validated for cadaveric samples. Nevertheless, the Physicians Council subgroup has voted to recommend laboratory testing for COVID-19 as part of donor screening, using PCR testing obtained via swab, if available. (See
         <a class="medical medical_review" href="/z/d/html/127582.html" rel="external">
          "COVID-19: Issues related to solid organ transplantation", section on 'Donor screening'
         </a>
         .)
        </p>
        <p>
         This class of materials eliminates the morbidity associated with autologous fascia harvest. However, allografts have consistently underperformed compared with autologous and synthetic materials.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Xenografts
         </span>
         <span class="headingEndMark">
          —
         </span>
         Xenografts are acellular extracts of collagen from nonhuman sources, harvested with or without additional extracellular matrix components  (
         <a class="graphic graphic_table graphicRef73182" href="/z/d/graphic/73182.html" rel="external">
          table 3
         </a>
         ). They differ in the source species (bovine or porcine), site of harvest (pericardium, dermis, or small intestine submucosa), and whether or not chemical crosslinking is used in the processing of the material [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
         It is unclear whether architectural differences due to harvest site (eg, dermis with high elastin content versus intestinal submucosa with no elastin content) affect in vivo performance.
        </p>
        <p>
         Some patients may object to the use of porcine or bovine implants due to religious or cultural issues.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h1">
          HOST RESPONSE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Histologic behavior to a class of material depends upon the physical and structural properties of the prosthesis. The type of host response is a key determinant of synthetic mesh-related complications. As an example, among patients undergoing a sacrocolpopexy, the risk of mesh exposure was 4.2 times greater for those who had polytetrafluoroethylene (PTFE) compared to those that used non-PTFE mesh [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Terminology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Host response to reconstructive materials is described by varying terminology [
         <a href="#rid7">
          7
         </a>
         ], as an example:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Incorporation: Graft infiltration by host cells, allowing neovascularization and collagen deposition throughout the material.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Encapsulation: Collagen and connective tissue deposit at the periphery of the material, rather than the infiltration of graft by host cells. (See
         <a class="local">
          'Encapsulation'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mixed response: Incorporation occurs at graft pores, and encapsulation occurs around the remaining material.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Resorption: Material is replaced by host neo-connective tissue.
        </p>
        <p>
        </p>
        <p>
         Materials that undergo encapsulation or mixed response are at increased risk of infection and erosion. (See
         <a class="local">
          'Classification'
         </a>
         below.)
        </p>
        <p>
         The key factor(s) for the host response to each type of material are as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Synthetic mesh: Fiber diameter, pore size, and weave or knit type.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Autografts: Autologous tissue, host response is rarely problematic.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Allografts: Key factor(s) have not been elucidated.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Xenografts: Removal of host cellular components and chemically crosslinking.
        </p>
        <p>
        </p>
        <p>
         The International Urogynecological Association (IUGA) and the International Continence Society (ICS) have published a Joint Terminology and Classification Report on mesh-related complications that classifies the event based upon category (asymptomatic, symptomatic, infection with or without abscess), location (vagina, urinary tract, bowel, skin or patient compromise), and timing since implantation (within 48 hours of surgery, until 6 months and beyond 6 months from surgery). Clinically, prosthetic material-related complications are manifested as exposures (mesh fibers protruding into the lumen of the vaginal or surrounding organs), mesh contraction or prominence (the wrinkling or shrinkage of the material projecting beyond the surface of the epithelium), infection (including sinus tract formation and abscess), bowel or bladder injury, or bleeding complications and systemic compromise. It is rare to have an infected, unexposed material. In some locations, such as the vagina, it is difficult to differentiate between infection and colonization, and clinical signs of infection are necessary to make the diagnosis. Furthermore, whether these clinical manifestations are due to host response or technical aspects of material use (eg, thickness of vaginal flaps) is unclear.
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Synthetic materials
         </span>
         <span class="headingEndMark">
          —
         </span>
         Host response to synthetic prosthetic materials depends on several factors: absorbability, pore size (space between fibrils), weave or knit (mono- or multifilament), and weight (mass per surface area mesh).
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h3">
          Absorbable versus nonabsorbable
         </span>
         <span class="headingEndMark">
          —
         </span>
         Both absorbable and nonabsorbable materials cause initial and chronic inflammatory tissue responses after being implanted [
         <a href="#rid8">
          8
         </a>
         ]. The quantity and quality of local inflammation depend directly on the specific material used.
        </p>
        <p>
         The implantation of absorbable material (eg, polyglactin 910 [Vicryl] or polyglycolic acid [Dexon]) elicits a chronic foreign body reaction and promotes fibroblast activity. After complete absorption (30 days for polyglactin 910; 90 days for polyglycolic acid), the prosthetic material is replaced by collagen-rich connective tissue [
         <a href="#rid9">
          9
         </a>
         ]. Absorbable materials are less likely to become infected than nonabsorbable materials and are less harmful to viscera [
         <a href="#rid10">
          10
         </a>
         ]. Based on animal studies, one disadvantage to absorbable implants is that the resultant scar tissue weakens after the material is absorbed and may not provide the necessary long-term repair strength [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
         Nonabsorbable prosthetic materials (eg, polypropylene [Prolene, Marlex]) are associated with more connective tissue reaction than absorbable materials. Thus, repair strength is increased due to the continuing presence of the implant and greater scar formation.
        </p>
        <p>
         Partially absorbable materials have been developed with the aim of decreasing the amount of permanent foreign material while maintaining mechanical resistance. These materials are composites of absorbable and nonabsorbable materials (eg, polypropylene with polyglactin [Vypro] or with poliglecaprone-25 [Ultrapro]) and are lightweight; few reports are available regarding clinical performance [
         <a href="#rid12">
          12,13
         </a>
         ]. (See
         <a class="local">
          'Weight'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h3">
          Pore size and weave
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pore size influences cellular infiltration, risk of infection, the tendency to form adhesions, and mesh density and flexibility [
         <a href="#rid14">
          14,15
         </a>
         ]. Macropores (&gt;75 microns; 1 mm = 1000 microns) allow for host cell colonization with collagen deposition and angiogenesis, although this has only been reported in animal studies [
         <a href="#rid16">
          16,17
         </a>
         ]. In addition, in vivo evidence suggests that the large pore allows unrestricted immune cell access and minimizes the risk of infection.
        </p>
        <p>
         Micropores (&lt;10 microns) result in restriction of fibroblast and immune cell colonization to the material surface (eg, PTFE). Therefore, collagen and connective tissue deposition occurs at the periphery rather than by infiltration by host cells. This process is called encapsulation [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
         In addition, microporous materials are at increased risk of becoming infected, as large immune cells (macrophages and natural killer cells, mean diameter 9 to 20 microns) cannot infiltrate the interstices (space between fibers) to phagocytose bacteria (&lt;1 micron) [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h3">
          Weight
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mesh weight, or density, is another descriptor for synthetic materials  (
         <a class="graphic graphic_figure graphicRef78709" href="/z/d/graphic/78709.html" rel="external">
          figure 1
         </a>
         ). Generally speaking, the weight is a measure of how much material is present per square meter.
        </p>
        <p>
         Weight and elasticity are determined by pore size. Meshes with larger pores generally have a lower weight and are more elastic than those with smaller pores. The larger the pores, the less material content and the more flexible the elicited scar [
         <a href="#rid18">
          18
         </a>
         ]. It has been postulated that lightweight materials may be less prone to infection or erosion than heavy-weight materials. Even amongst macroporous materials, those with pore size &lt;1 mm elicit suboptimal tissue in-growth, chronic inflammation, and can undergo fibrotic encapsulation [
         <a href="#rid19">
          19,20
         </a>
         ]. Materials with pore size &lt;1 mm appear to induce stress shielding, a process in which the rigid material impairs force transmission through the tissue leading to suboptimal vaginal smooth muscle response, atrophy, and degeneration. Ideally, surgeons should seek to use materials with pore sizes &gt;1 mm.
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h3">
          Classification
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nonabsorbable synthetic materials are generally described by type, a classification based on pore size and weave  (
         <a class="graphic graphic_figure graphicRef78709" href="/z/d/graphic/78709.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid21">
          21
         </a>
         ]. There are four types  (
         <a class="graphic graphic_figure graphicRef78709" href="/z/d/graphic/78709.html" rel="external">
          figure 1
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Type I – Macroporous (&gt;75 microns), monofilament polypropylene (eg, Prolene, Marlex). Type I meshes are further subdivided into heavy-, mid-, and lightweight materials.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Combination absorbable and nonabsorbable mesh material, such as polypropylene with either polyglactin (eg, Vypro) or with poliglecaprone (eg, Ultrapro), are also available. The absorbable component provides temporary wound integrity and maximizes pore size (as the absorbable component undergoes hydrolysis during the intervening two to three months postimplantation) to minimize the risk of mesh exposure.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Type II – Microporous (&lt;10 microns), eg, expanded polytetrafluoroethylene (eg, Gore-tex).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Type III – Macroporous (&gt;75 microns) grafts with either microporous components or multifilament fiber structure (eg, polyethylene [Mersilene]). Histologic behavior is similar to type II materials. This category includes some polypropylene materials (eg, ObTape [heat-bonded, heat-welded polypropylene with microporous components] and IVS Tunneler [multifilament polypropylene]). Both materials have been associated with increased rates of infections and erosion [
         <a href="#rid22">
          22
         </a>
         ]; ObTape has been removed from the market, and IVS Tunneler is not being marketed.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Type IV – Submicroscopic pore size (eg, polypropylene sheet [Cellgard]). These are not commonly used in gynecologic surgery.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Allograft processing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Allograft processing is intended to render a graft nonimmunogenic. The methods companies use to process human tissue to produce allografts vary, and details are not publicly disclosed  (
         <a class="graphic graphic_table graphicRef63852" href="/z/d/graphic/63852.html" rel="external">
          table 2
         </a>
         ), thereby interfering with evidence-based comparisons among allografts.
        </p>
        <p>
         There are at least four major steps in allograft processing:
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h3">
          Harvesting
         </span>
         <span class="headingEndMark">
          —
         </span>
         Harvesting of fascia lata and dermis is done aseptically from cadavers. For dermis products, the epidermis is mechanically or chemically separated from the underlying dermis; the collagen matrix is then extracted from the dermis.
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h3">
          Cell removal
         </span>
         <span class="headingEndMark">
          —
         </span>
         After harvesting, the material is made acellular by washing it in a solution to extract cellular components. These processes render the allograft nonimmunogenic by eliminating cell surface proteins (eg, human histocompatibility antigen, HLA) and sugar moieties. The solvents must remove cellular debris without permanently denaturing the protein scaffold.
        </p>
        <p>
         Despite assertions by manufacturers, it appears that the cellular extraction process could be better [
         <a href="#rid23">
          23
         </a>
         ]. In one study, the HLA type of allograft donors could still be identified (using the polymerase chain reaction) in freeze-dried and Tutoplast-processed grafts; Repliform interfered with the assay in the study, and its antigenicity could not be determined. These data suggest that not all contaminating DNA had been extracted. However, this finding does not signify that the grafts were immunogenic. Host rejection is mediated by host lymphocyte detection of cell surface proteins and sugar moieties, not DNA or other intracellular components.
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h3">
          Preservation and sterilization
         </span>
         <span class="headingEndMark">
          —
         </span>
         The collagen and extracellular matrix are preserved via lyophilization (freeze-dried under vacuum) or solvent dehydration. In some tissue banks, the graft is then terminally sterilized (usually with gamma irradiation).
        </p>
        <p>
         The processes employed for these steps appear to affect the final graft strength. As an example, the rate of lyophilization alters the size of ice crystal formation (the more ice crystals formed, the weaker the final product), and the terminal sterilization temperature influences the degree of free radical formation.
        </p>
        <p>
         Both lyophilization and sterilization affect the final integrity of the material and, theoretically, graft performance. However, the effect of preimplantation biomechanical characteristics of a graft on in vivo behavior is controversial [
         <a href="#rid7">
          7,24-28
         </a>
         ]. No data on postimplantation biomechanical testing exist for allografts; it appears that preimplantation mechanical testing does not predict in vivo behavior of xenografts [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
         In fact, the few studies that have compared different allografts by preimplantation strength are inconsistent with reports of clinical performance. As an example, one study reported that the preimplantation maximum load to failure (minimum force needed to tear the tissue) and stiffness were significantly higher for solvent dehydrated compared with freeze-dried fascia lata [
         <a href="#rid24">
          24
         </a>
         ]. Nevertheless, solvent-dehydrated allografts have consistently been reported to result in early failure after pubovaginal sling [
         <a href="#rid25">
          25,26
         </a>
         ], sacrocolpopexy [
         <a href="#rid27">
          27
         </a>
         ], and vaginal reinforced repairs [
         <a href="#rid28">
          28
         </a>
         ]. Similarly, the only study that evaluated vaginal repair with a freeze-dried graft reported a high failure rate [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h2">
          Xenograft processing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Similar to allografts, xenografts processing includes harvesting, cell removal, preservation, and sterilization. These processes are generally proprietary, and thus comparisons among different grafts are difficult. In our experience, some patients have had increased tissue reactions with xenografts, raising concerns about how well the processes remove cellular debris. (See
         <a class="local">
          'Allograft processing'
         </a>
         above.)
        </p>
        <p>
         In addition, xenografts undergo chemical crosslinking, which is one of the key determinants of the host response to xenografts  (
         <a class="graphic graphic_table graphicRef73182" href="/z/d/graphic/73182.html" rel="external">
          table 3
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h3">
          Crosslinking
         </span>
         <span class="headingEndMark">
          —
         </span>
         Noncrosslinked xenografts (eg, Surgisis, Xenform) are purported to serve as biologic scaffolding for fibroblast and angioblast ingrowth; they are replaced by host connective tissue at varying rates, depending on material thickness, method of freezing, and site of implantation [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
         Conversely, cross-linked materials (eg, Pelvicol) are functionally nonporous. As a result, host cellular infiltration does not occur, and the material is surrounded by a connective tissue envelope (ie, encapsulation, similar to synthetic type II materials) [
         <a href="#rid5">
          5
         </a>
         ]. (See
         <a class="local">
          'Classification'
         </a>
         above.)
        </p>
        <p>
         If crosslinked materials are perforated before implantation (eg, Pelvisoft and Fortagen), they undergo a mixed response with incorporation at the perforations and encapsulation in the remainder of the material (similar to what is observed for type III synthetic materials) [
         <a href="#rid5">
          5
         </a>
         ]. (See
         <a class="local">
          'Classification'
         </a>
         above.)
        </p>
        <p>
         Although crosslinking is performed to permanently stabilize the material, crosslinked graft resorption over time is an area of concern. According to the manufacturer report only, the process of resorption would be different for crosslinked and non-crosslinked grafts.
        </p>
        <p>
         It is unknown whether eventual graft loss affects the structural integrity of the repair. Furthermore, it remains to be elucidated if resorption occurs in all patients implanted with a crosslinked graft or only in a subset of patients rejecting the graft. The following studies illustrate this:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A small histopathologic study evaluated females who had undergone placement of a midurethral sling using a crosslinked porcine dermal collagen implant (Pelvicol) and who required sling revision due to recurrent stress urinary incontinence or urinary retention [
         <a href="#rid30">
          30
         </a>
         ]. Time from graft placement to biopsy ranged from 15 to 67 months. Although the graft remained encapsulated in the early biopsy specimens, there was a progressive increase in the immunologic response at the graft-host interface at 21 weeks. Histiocyte and multinucleated giant cell infiltration of the graft was detected by 42 weeks [
         <a href="#rid30">
          30
         </a>
         ]. No residual graft was found in the 58- and 67-week samples, suggesting that the materials were resorbed in the interim [
         <a href="#rid5">
          5,30
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In another study, females with a Pelvicol reinforced posterior repair were evaluated upon reoperation one year postoperatively; no residual Pelvicol was found [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2745673414">
         <span class="h2">
          Encapsulation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Encapsulation is a host response in which collagen and connective tissue deposit at the periphery of the material rather than being infiltrated. Using mesh materials that become encapsulated should be avoided for midurethral sling procedures and vaginal prolapse repairs. Four different kits introduced since the mid-1990s for urinary incontinence (ProteGen, ObTape, and UraTape) and for vaginal prolapse repair (IVS Tunneler) have elicited an encapsulation response (eg, a type II or type III mesh). They were approved by the US Food and Drug Administration but were removed from the market within two to three years of introduction due to an unacceptably high rate of complications (sinus tract formation, urethral and bladder fistula, chronic discharge, elevated rates of exposure) [
         <a href="#rid32">
          32
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14217.html" rel="external">
          "Surgical management of stress urinary incontinence in females: Retropubic midurethral slings", section on 'Synthetic mesh complications'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H468407067">
         <span class="h1">
          USE OF RECONSTRUCTIVE MATERIALS
         </span>
        </p>
        <p class="headingAnchor" id="H1620871188">
         <span class="h2">
          Hernia repair
         </span>
         <span class="headingEndMark">
          —
         </span>
         The use of prosthetic material dramatically reduces the incidence of recurrence associated with ventral, inguinal, and femoral hernia repair. Polypropylene is the most common material used. (See
         <a class="medical medical_review" href="/z/d/html/3687.html" rel="external">
          "Overview of treatment for inguinal and femoral hernia in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3688.html" rel="external">
          "Overview of abdominal wall hernias in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3065504794">
         <span class="h2">
          Pelvic organ prolapse
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pelvic organ prolapse (POP) and urinary incontinence are common comorbid disorders in females and can greatly impact the quality of life [
         <a href="#rid33">
          33
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8072.html" rel="external">
          "Pelvic organ prolapse in females: Epidemiology, risk factors, clinical manifestations, and management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16920.html" rel="external">
          "Surgical approach to rectal procidentia (rectal prolapse)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There are four categories of reconstructive surgical materials: synthetic material, autografts, allografts, and xenografts  (
         <a class="graphic graphic_table graphicRef72868" href="/z/d/graphic/72868.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Types of materials'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The host response to a class of material depends upon the physical and structural properties of the prosthesis. Synthetic material pore size determines host response. The type of response predisposes to an increased risk of infection and mesh exposure. (See
         <a class="local">
          'Host response'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Allograft processing is intended to render a material nonimmunogenic. Processing techniques vary by manufacturer, and information is not publicly disclosed, thus limiting evidence-based comparison of allografts. (See
         <a class="local">
          'Allograft processing'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chemical crosslinking is a key determinant of the host response to xenografts. (See
         <a class="local">
          'Xenograft processing'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Macroporous polypropylene mesh is the only material that has consistently been shown to improve outcomes following hernia and abdominal prolapse repairs and midurethral slings for urinary incontinence. Without mesh, these reconstructions are followed by high recurrence rates (eg, hernia, prolapse). (See
         <a class="local">
          'Use of reconstructive materials'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Huebner M, Hsu Y, Fenner DE. The use of graft materials in vaginal pelvic floor surgery. Int J Gynaecol Obstet 2006; 92:279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Albo ME, Richter HE, Brubaker L, et al. Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med 2007; 356:2143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walter AJ, Hentz JG, Magrina JF, Cornella JL. Harvesting autologous fascia lata for pelvic reconstructive surgery: techniques and morbidity. Am J Obstet Gynecol 2001; 185:1354.
          </a>
         </li>
         <li class="breakAll">
          American Association of Tissue Banks: COVID-19 Update. https://www.aatb.org/content/bulletin-20-10 (Accessed on July 02, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trabuco EC, Klingele CJ, Gebhart JB. Xenograft use in reconstructive pelvic surgery: a review of the literature. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:555.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cundiff GW, Varner E, Visco AG, et al. Risk factors for mesh/suture erosion following sacral colpopexy. Am J Obstet Gynecol 2008; 199:688.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trabuco EC, Zobitz ME, Klingele CJ, Gebhart JB. Effect of host response (incorporation, encapsulation, mixed incorporation and encapsulation, or resorption) on the tensile strength of graft-reinforced repair in the rat ventral hernia model. Am J Obstet Gynecol 2007; 197:638.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klinge U, Klosterhalfen B, Müller M, Schumpelick V. Foreign body reaction to meshes used for the repair of abdominal wall hernias. Eur J Surg 1999; 165:665.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klinge U, Schumpelick V, Klosterhalfen B. Functional assessment and tissue response of short- and long-term absorbable surgical meshes. Biomaterials 2001; 22:1415.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen CC, Ridgeway B, Paraiso MF. Biologic grafts and synthetic meshes in pelvic reconstructive surgery. Clin Obstet Gynecol 2007; 50:383.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barbolt TA. Biology of polypropylene/polyglactin 910 grafts. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17 Suppl 1:S26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bellón JM, Rodríguez M, García-Honduvilla N, et al. Partially absorbable meshes for hernia repair offer advantages over nonabsorbable meshes. Am J Surg 2007; 194:68.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Achtari C, Hiscock R, O'Reilly BA, et al. Risk factors for mesh erosion after transvaginal surgery using polypropylene (Atrium) or composite polypropylene/polyglactin 910 (Vypro II) mesh. Int Urogynecol J Pelvic Floor Dysfunct 2005; 16:389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iglesia CB, Fenner DE, Brubaker L. The use of mesh in gynecologic surgery. Int Urogynecol J Pelvic Floor Dysfunct 1997; 8:105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Falagas ME, Velakoulis S, Iavazzo C, Athanasiou S. Mesh-related infections after pelvic organ prolapse repair surgery. Eur J Obstet Gynecol Reprod Biol 2007; 134:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           White, RA. The effect of porosity and biomaterial on the healing and long-term mechanical properties of vascular prostheses. ASAIO J 1988; 11:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bobyn JD, Wilson GJ, MacGregor DC, et al. Effect of pore size on the peel strength of attachment of fibrous tissue to porous-surfaced implants. J Biomed Mater Res 1982; 16:571.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cobb WS, Burns JM, Peindl RD, et al. Textile analysis of heavy weight, mid-weight, and light weight polypropylene mesh in a porcine ventral hernia model. J Surg Res 2006; 136:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barone WR, Moalli PA, Abramowitch SD. Textile properties of synthetic prolapse mesh in response to uniaxial loading. Am J Obstet Gynecol 2016; 215:326.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jallah Z, Liang R, Feola A, et al. The impact of prolapse mesh on vaginal smooth muscle structure and function. BJOG 2016; 123:1076.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amid PK. Classification of biomaterials and their related complications in abdominal wall hernia surgery. Hernia 1997; 1:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baessler K, Hewson AD, Tunn R, et al. Severe mesh complications following intravaginal slingplasty. Obstet Gynecol 2005; 106:713.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fitzgerald MP, Mollenhauer J, Brubaker L. The antigenicity of fascia lata allografts. BJU Int 2000; 86:826.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemer ML, Chaikin DC, Blaivas JG. Tissue strength analysis of autologous and cadaveric allografts for the pubovaginal sling. Neurourol Urodyn 1999; 18:497.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang YH, Lin AT, Chen KK, et al. High failure rate using allograft fascia lata in pubovaginal sling surgery for female stress urinary incontinence. Urology 2001; 58:943.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McBride AW, Ellerkmann RM, Bent AE, Melick CF. Comparison of long-term outcomes of autologous fascia lata slings with Suspend Tutoplast fascia lata allograft slings for stress incontinence. Am J Obstet Gynecol 2005; 192:1677.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Culligan PJ, Blackwell L, Goldsmith LJ, et al. A randomized controlled trial comparing fascia lata and synthetic mesh for sacral colpopexy. Obstet Gynecol 2005; 106:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gandhi S, Goldberg RP, Kwon C, et al. A prospective randomized trial using solvent dehydrated fascia lata for the prevention of recurrent anterior vaginal wall prolapse. Am J Obstet Gynecol 2005; 192:1649.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ward RM, Sung VW, Clemons JL, Myers DL. Vaginal paravaginal repair with an AlloDerm graft: Long-term outcomes. Am J Obstet Gynecol 2007; 197:670.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gandhi S, Kubba LM, Abramov Y, et al. Histopathologic changes of porcine dermis xenografts for transvaginal suburethral slings. Am J Obstet Gynecol 2005; 192:1643.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Altman D, Zetterström J, López A, et al. Functional and anatomic outcome after transvaginal rectocele repair using collagen mesh: a prospective study. Dis Colon Rectum 2005; 48:1233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ulmsten U, Henriksson L, Johnson P, Varhos G. An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 1996; 7:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Helström L, Nilsson B. Impact of vaginal surgery on sexuality and quality of life in women with urinary incontinence or genital descensus. Acta Obstet Gynecol Scand 2005; 84:79.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 2879 Version 22.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16426613" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : The use of graft materials in vaginal pelvic floor surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17517855" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Burch colposuspension versus fascial sling to reduce urinary stress incontinence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11744909" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Harvesting autologous fascia lata for pelvic reconstructive surgery: techniques and morbidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11744909" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Harvesting autologous fascia lata for pelvic reconstructive surgery: techniques and morbidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17225930" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Xenograft use in reconstructive pelvic surgery: a review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18976976" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Risk factors for mesh/suture erosion following sacral colpopexy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18060961" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Effect of host response (incorporation, encapsulation, mixed incorporation and encapsulation, or resorption) on the tensile strength of graft-reinforced repair in the rat ventral hernia model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10452261" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Foreign body reaction to meshes used for the repair of abdominal wall hernias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11336316" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Functional assessment and tissue response of short- and long-term absorbable surgical meshes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17513926" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Biologic grafts and synthetic meshes in pelvic reconstructive surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16738744" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Biology of polypropylene/polyglactin 910 grafts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17560912" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Partially absorbable meshes for hernia repair offer advantages over nonabsorbable meshes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15657636" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Risk factors for mesh erosion after transvaginal surgery using polypropylene (Atrium) or composite polypropylene/polyglactin 910 (Vypro II) mesh.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9297599" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : The use of mesh in gynecologic surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17459563" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Mesh-related infections after pelvic organ prolapse repair surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : The effect of porosity and biomaterial on the healing and long-term mechanical properties of vascular prostheses
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7130213" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Effect of pore size on the peel strength of attachment of fibrous tissue to porous-surfaced implants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16996087" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Textile analysis of heavy weight, mid-weight, and light weight polypropylene mesh in a porcine ventral hernia model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27001219" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Textile properties of synthetic prolapse mesh in response to uniaxial loading.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26301457" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : The impact of prolapse mesh on vaginal smooth muscle structure and function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Classification of biomaterials and their related complications in abdominal wall hernia surgery
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16199626" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Severe mesh complications following intravaginal slingplasty.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11069408" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : The antigenicity of fascia lata allografts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10494122" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Tissue strength analysis of autologous and cadaveric allografts for the pubovaginal sling.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11744464" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : High failure rate using allograft fascia lata in pubovaginal sling surgery for female stress urinary incontinence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15902176" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Comparison of long-term outcomes of autologous fascia lata slings with Suspend Tutoplast fascia lata allograft slings for stress incontinence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15994614" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : A randomized controlled trial comparing fascia lata and synthetic mesh for sacral colpopexy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15902172" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : A prospective randomized trial using solvent dehydrated fascia lata for the prevention of recurrent anterior vaginal wall prolapse.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18060976" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Vaginal paravaginal repair with an AlloDerm graft: Long-term outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15902171" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Histopathologic changes of porcine dermis xenografts for transvaginal suburethral slings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15868220" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Functional and anatomic outcome after transvaginal rectocele repair using collagen mesh: a prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8798092" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15603572" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Impact of vaginal surgery on sexuality and quality of life in women with urinary incontinence or genital descensus.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
